Revenues for the quarter totaled $749,000, versus revenues of $1.2 million for
the comparable period in 2002 and $784,000 for the previous quarter ended March
31, 2003. The net loss attributable to common stockholders for the quarter was
$8.0 million, or $0.72 per common share, compared to a net loss of $5.0 million,
or $2.55 per common share for the three months ended June 30, 2002. The net loss
for the second quarter of 2003 and 2002 included $4.4 million and $3.1 million,
respectively, in non-cash charges that were primarily related to the grants of
common stock and options and warrants as compensation for services and non-cash
interest expense related primarily to the accounting for Calypte's convertible
debt financing instruments.
For the six months ended June 30, 2003, revenues totaled $1.5 million, versus
revenues of $2.4 million for the same period last year. The net loss
attributable to common stockholders was $14.3 million, or $1.70 per common
share, compared to a net loss of $5.6 million, or $3.41 per common share for the
six months ended June 30, 2002. The net loss for the six months ended June 30,
2003 and 2002 included $8.3 million and $3.3 million, respectively, in non-cash
charges that were primarily related to the grants of common stock and options
and warrants as compensation for services and non-cash interest expense related
primarily to the accounting for Calypte's convertible debt financing
instruments. In 2002, there were also $1.3 million in credits related to a
non-cash gain on settlement of debt.
"Calypte continues to move ahead as we aggressively execute our business plan,"
stated Tony Cataldo LOL